Skip to main content
. 2020 May 22;13(9):100796. doi: 10.1016/j.tranon.2020.100796

Figure 5.

Figure 5

Inducing synthetic lethality in HCC by suppressing DSB repair.

Mechanistic diagram on adjunct therapy using PARP inhibitors and HDR inhibitors in HCC. Blocking both NHEJ and HDR DSB repair would lead to accumulation of DNA damages in HDR-capable HCC cells and thus induce cell death.